Skip to main content
Erschienen in: Heart and Vessels 2/2016

01.02.2016 | Original Article

Association of dietary iron restriction with left ventricular remodeling after myocardial infarction in mice

verfasst von: Akiyo Eguchi, Yoshiro Naito, Toshihiro Iwasaku, Yoshitaka Okuhara, Daisuke Morisawa, Hisashi Sawada, Koichi Nishimura, Makiko Oboshi, Kenichi Fujii, Toshiaki Mano, Tohru Masuyama, Shinichi Hirotani

Erschienen in: Heart and Vessels | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Several epidemiologic studies have reported that body iron status and dietary iron intake are related to an increased risk of acute myocardial infarction (MI). However, it is completely unknown whether dietary iron reduction impacts the development of left ventricular (LV) remodeling after MI. Here, we investigate the effect of dietary iron restriction on the development of LV remodeling after MI in an experimental model. MI was induced in C57BL/6 J mice (9–11 weeks of age) by the permanent ligation of the left anterior descending coronary artery (LAD). At 2 weeks after LAD ligation, mice were randomly divided into two groups and were given a normal diet or an iron-restricted diet for 4 weeks. Sham operation without LAD ligation was also performed as controls. MI mice exhibited increased LV dilatation and impaired LV systolic function that was associated with cardiomyocyte hypertrophy and interstitial fibrosis in the remote area, as compared with the controls at 6 weeks after MI. In contrast, dietary iron restriction attenuated LV dilatation and impaired LV systolic function coupled to cardiomyocyte hypertrophy and interstitial fibrosis in the remote area. Importantly, cardiac expression of cellular iron transport proteins, transferrin receptor 1 and divalent metal transporter 1 was increased in the remote area of MI mice compared with the controls. Dietary iron restriction attenuated the development of LV remodeling after MI in mice. Cellular iron transport might play a role in the pathophysiological mechanism of LV remodeling after MI.
Literatur
1.
Zurück zum Zitat Corti MC, Gaziano M, Hennekens CH (1997) Iron status and risk of cardiovascular disease. Ann Epidemiol 7:62–68CrossRefPubMed Corti MC, Gaziano M, Hennekens CH (1997) Iron status and risk of cardiovascular disease. Ann Epidemiol 7:62–68CrossRefPubMed
2.
Zurück zum Zitat Basuli D, Stevens RG, Torti FM, Torti SV (2014) Epidemiological associations between iron and cardiovascular disease and diabetes. Front Pharmacol 5:117PubMedCentralPubMed Basuli D, Stevens RG, Torti FM, Torti SV (2014) Epidemiological associations between iron and cardiovascular disease and diabetes. Front Pharmacol 5:117PubMedCentralPubMed
3.
Zurück zum Zitat Kaluza J, Wolk A, Larsson SC (2013) Heme iron intake and risk of stroke: a prospective study of men. Stroke 44:334–339CrossRefPubMed Kaluza J, Wolk A, Larsson SC (2013) Heme iron intake and risk of stroke: a prospective study of men. Stroke 44:334–339CrossRefPubMed
4.
Zurück zum Zitat Sullivan JL (2009) Iron in arterial plaque: modifiable risk factor for atherosclerosis. Biochim Biophys Acta 1790:718–723CrossRefPubMed Sullivan JL (2009) Iron in arterial plaque: modifiable risk factor for atherosclerosis. Biochim Biophys Acta 1790:718–723CrossRefPubMed
5.
Zurück zum Zitat Zhang W, Iso H, Ohira T, Date OC, Tanabe N, Kikuchi S, Tamakoshi A (2012) Associations of dietary iron intake with mortality from cardiovascular disease: the JACC study. J Epidemiol 22:484–493CrossRefPubMed Zhang W, Iso H, Ohira T, Date OC, Tanabe N, Kikuchi S, Tamakoshi A (2012) Associations of dietary iron intake with mortality from cardiovascular disease: the JACC study. J Epidemiol 22:484–493CrossRefPubMed
6.
Zurück zum Zitat Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW (2008) Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 100:996–1002CrossRefPubMed Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW (2008) Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 100:996–1002CrossRefPubMed
7.
Zurück zum Zitat Tuomainen TP, Punnonen K, Nyyssönen K, Salonen JT (1998) Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97:1461–1466CrossRefPubMed Tuomainen TP, Punnonen K, Nyyssönen K, Salonen JT (1998) Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97:1461–1466CrossRefPubMed
8.
Zurück zum Zitat Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R (1992) High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86:803–811CrossRefPubMed Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R (1992) High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86:803–811CrossRefPubMed
9.
Zurück zum Zitat Kaluza J, Larsson SC, Håkansson N, Wolk A (2014) Heme iron intake and acute myocardial infarction: a prospective study of men. Int J Cardiol 172:155–160CrossRefPubMed Kaluza J, Larsson SC, Håkansson N, Wolk A (2014) Heme iron intake and acute myocardial infarction: a prospective study of men. Int J Cardiol 172:155–160CrossRefPubMed
10.
Zurück zum Zitat Klipstein-Grobusch K, Grobbee DE, den Breeijen JH, Boeing H, Hofman A, Witteman JC (1999) Dietary iron and risk of myocardial infarction in the Rotterdam Study. Am J Epidemiol 149:421–428CrossRefPubMed Klipstein-Grobusch K, Grobbee DE, den Breeijen JH, Boeing H, Hofman A, Witteman JC (1999) Dietary iron and risk of myocardial infarction in the Rotterdam Study. Am J Epidemiol 149:421–428CrossRefPubMed
11.
Zurück zum Zitat Tavani A, Gallus S, Bosetti C, Parpinel M, Negri E, La Vecchia C (2006) Dietary iron intake and risk of non-fatal acute myocardial infarction. Public Health Nutr 9:480–484PubMed Tavani A, Gallus S, Bosetti C, Parpinel M, Negri E, La Vecchia C (2006) Dietary iron intake and risk of non-fatal acute myocardial infarction. Public Health Nutr 9:480–484PubMed
12.
Zurück zum Zitat Naito Y, Hirotani S, Sawada H, Akahori H, Tsujino T, Masuyama T (2011) Dietary iron restriction prevents hypertensive cardiovascular remodeling in Dahl salt-sensitive rats. Hypertension 57:497–504CrossRefPubMed Naito Y, Hirotani S, Sawada H, Akahori H, Tsujino T, Masuyama T (2011) Dietary iron restriction prevents hypertensive cardiovascular remodeling in Dahl salt-sensitive rats. Hypertension 57:497–504CrossRefPubMed
13.
Zurück zum Zitat Zhang BH, Guo CX, Wang HX, Lu LQ, Wang YJ, Zhang LK, Du FH, Zeng XJ (2014) Cardioprotective effects of adipokine apelin on myocardial infarction. Heart Vessels 29:679–689CrossRefPubMed Zhang BH, Guo CX, Wang HX, Lu LQ, Wang YJ, Zhang LK, Du FH, Zeng XJ (2014) Cardioprotective effects of adipokine apelin on myocardial infarction. Heart Vessels 29:679–689CrossRefPubMed
14.
Zurück zum Zitat Naito Y, Fujii A, Sawada H, Hirotani S, Iwasaku T, Eguchi A, Ohyanagi M, Tsujino T, Masuyama T (2012) Effect of iron restriction on renal damage and mineralocorticoid receptor signaling in a rat model of chronic kidney disease. J Hypetens 30:2192–2201CrossRef Naito Y, Fujii A, Sawada H, Hirotani S, Iwasaku T, Eguchi A, Ohyanagi M, Tsujino T, Masuyama T (2012) Effect of iron restriction on renal damage and mineralocorticoid receptor signaling in a rat model of chronic kidney disease. J Hypetens 30:2192–2201CrossRef
15.
Zurück zum Zitat Nagai T, Anzai T, Mano Y, Kaneko H, Anzai A, Sugano Y, Maekawa Y, Takahashi T, Yoshikawa T, Fukuda K (2013) Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling. Heart Vessels 28:404–411CrossRefPubMed Nagai T, Anzai T, Mano Y, Kaneko H, Anzai A, Sugano Y, Maekawa Y, Takahashi T, Yoshikawa T, Fukuda K (2013) Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling. Heart Vessels 28:404–411CrossRefPubMed
16.
Zurück zum Zitat Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, Masuyama T (2009) Adaptive response of the heart to long term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol 296:H585–H593CrossRefPubMed Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, Masuyama T (2009) Adaptive response of the heart to long term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol 296:H585–H593CrossRefPubMed
17.
18.
Zurück zum Zitat Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML (2006) The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 121:144–158CrossRefPubMed Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML (2006) The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 121:144–158CrossRefPubMed
19.
20.
21.
Zurück zum Zitat Bolli R, Patel BS, Jeroudi MO, Li XY, Triana JF, Lai EK, McCay PB (1990) Iron-mediated radical reactions upon reperfusion contribute to myocardial “stunning”. Am J Physiol 259:H1901–H1911PubMed Bolli R, Patel BS, Jeroudi MO, Li XY, Triana JF, Lai EK, McCay PB (1990) Iron-mediated radical reactions upon reperfusion contribute to myocardial “stunning”. Am J Physiol 259:H1901–H1911PubMed
22.
Zurück zum Zitat Ambrosio G, Zweier JL, Jacobus WE, Weisfeldt ML, Flaherty JT (1987) Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation 76:906–915CrossRefPubMed Ambrosio G, Zweier JL, Jacobus WE, Weisfeldt ML, Flaherty JT (1987) Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation 76:906–915CrossRefPubMed
Metadaten
Titel
Association of dietary iron restriction with left ventricular remodeling after myocardial infarction in mice
verfasst von
Akiyo Eguchi
Yoshiro Naito
Toshihiro Iwasaku
Yoshitaka Okuhara
Daisuke Morisawa
Hisashi Sawada
Koichi Nishimura
Makiko Oboshi
Kenichi Fujii
Toshiaki Mano
Tohru Masuyama
Shinichi Hirotani
Publikationsdatum
01.02.2016
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 2/2016
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-014-0621-5

Weitere Artikel der Ausgabe 2/2016

Heart and Vessels 2/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.